IDiyas

For the Inventor, By the Inventor

Frankfurt am Main, Germany

Gunther J Riess

USPTO Granted Patents = 9

Average Co-Inventor Count = 4.3

ph-index = 3

Forward Citations = 76(Granted Patents)


Location History:

  • Frankfurt-am-Main, DE (1990 - 1998)
  • Hattersheim, DE (1998 - 2000)

Company Filing History:

goldMedal9 out of 6,662 
 
Hoechst Aktiengesellschaft
 patents

Years Active: 1990-2000

Loading Chart...
9 patents (USPTO):Explore Patents
1. 6114349 - Substituted quinoline derivatives with antiviral action (2000-09-05),
2. 5994307 - Methods of treatment with novel antibiotic feglymycin (1999-11-30),
3. 5891851 - Antibiotic, feglymycin, processes for its preparation and its use (1999-04-06),
4. 5830743 - Process for the preparation of glutarylacylase in large quantities (1998-11-03),
5. 5798365 - Substituted quinoline derivatives, a process for their preparation, and (1998-08-25),
6. 5723461 - Quinoxalines, a process for their preparation and their use (1998-03-03),
7. 5506202 - Insulin derivatives, a process for the preparation thereof, the use (1996-04-09),
8. 5426036 - Processes for the preparation of foreign proteins in streptomycetes (1995-06-20),
9. 4918007 - Promoter arrangement for streptomycetes vectors (1990-04-17),

Title: Gunther J Riess: Innovator in Antiviral and Antibiotic Research

Introduction

Gunther J Riess is a prominent inventor based in Frankfurt am Main, Germany. He has made significant contributions to the fields of antiviral and antibiotic research, holding a total of 9 patents. His work has been instrumental in developing novel treatments that address critical health challenges.

Latest Patents

Among his latest patents are "Substituted quinoline derivatives with antiviral action" and "Methods of treatment with novel antibiotic feglymycin." The latter invention relates to the antibiotic feglymycin, detailing processes for its preparation and use. Feglymycin is represented by the structural formula (SEQ. ID. NO. 1).

Career Highlights

Gunther J Riess has been associated with Hoechst Aktiengesellschaft, a leading company in the pharmaceutical industry. His innovative work has positioned him as a key figure in the development of new therapeutic agents.

Collaborations

Throughout his career, Gunther has collaborated with notable colleagues, including Laszlo Vertesy and Manfred Rosner. These partnerships have further enhanced the impact of his research and inventions.

Conclusion

Gunther J Riess continues to be a vital contributor to the fields of antiviral and antibiotic research, with a strong portfolio of patents that reflect his innovative spirit and dedication to improving healthcare solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…